US FDA Declares New Treatment for Neuroblastoma an Orphan Drug
Biopharmaceutical company CorMEdix Inc. announced on Friday, February 23rd that its product taurolidine received orphan drug status from the United States Food and Drug Administration (US FDA). Taurolidine exists currently…